January 2, 2026 · Form 4 insider transaction
Golden Lee Scott bought 18,750 shares of PTC Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.; Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.